This explains why there is an increasing trend for selecting surrogate endpoints as the primary outcome, while overall survival as a primary endpoint is decreasing 11 .
← all excerpts
Outcome switching in randomized controlled oncology trials reporting on surrogate endpoints: a cross-sectional analysis.
1
—
—